Vericel director Zerbe proposes $116K share sale

The notice lists a May 19, 2026 Rule 10b5-1 plan adoption date alongside two earlier sales of 2,500 and 3,000 shares.

Available on EDGAR 11/09/2026 - 04:29 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:29 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Vericel Corp (VCEL) director Robert L. Zerbe filed a notice of a proposed sale of 2,000 common shares, with an aggregate market value of $115,753.49 and an approximate sale date of November 9, 2026. The securities table lists a cash-paid stock option exercise from the issuer for 2,000 shares on that date, and a Rule 10b5-1 plan adoption date of May 19, 2026. The notice also reports two sales during the prior three months by Robert Zerbe: 2,500 shares on November 4, 2026, for gross proceeds of $113,502.00, and 3,000 shares on November 5, 2026, for gross proceeds of $156,682.25.

Key Figures

Proposed sale: 2,000 common shares Aggregate market value: $115,753.49 Prior sale: 2,500 common shares +4 more

7 metrics

Proposed sale 2,000 common shares Approximate sale date: November 9, 2026

Aggregate market value $115,753.49 Proposed sale

Prior sale 2,500 common shares November 4, 2026

Gross proceeds $113,502.00 Prior sale on November 4, 2026

Prior sale 3,000 common shares November 5, 2026

Gross proceeds $156,682.25 Prior sale on November 5, 2026

Rule 10b5-1 plan adoption date May 19, 2026 Date listed in the notice

Key Terms

Rule 10b5-1, Stock Option Exercise, Aggregate Market Value, Gross Proceeds

4 terms

Rule 10b5-1 regulatory

"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Stock Option Exercise financial

"Nature of Acquisition Transaction"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Gross Proceeds financial

"Gross Proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VCEL shares did Robert L. Zerbe propose to sell?

Robert L. Zerbe, a director of Vericel Corp (VCEL), reported a proposed sale of 2,000 common shares with an aggregate market value of $115,753.49 and an approximate sale date of November 9, 2026. The notice lists May 19, 2026 as the Rule 10b5-1 plan adoption date.

What prior VCEL sales does Robert Zerbe's notice report?

The notice reports a sale of 2,500 shares on November 4, 2026, for gross proceeds of $113,502.00, and a sale of 3,000 shares on November 5, 2026, for gross proceeds of $156,682.25.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001220363
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vericel Corp
SEC File Number	001-35280
Address of Issuer	25 BLUE SKY DRIVE BURLINGTON MASSACHUSETTS 01803
Phone	6175885555
Name of Person for Whose Account the Securities are To Be Sold	ZERBE ROBERT L MD
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2000	115753.49	51029770	11/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/09/2026	Stock Option Exercise	Issuer			2000	11/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Zerbe 25 Blue Sky Drive Burlington MA 01803	Common	11/04/2026	2500	113502.00
Robert Zerbe 25 Blue Sky Drive Burlington MA 01803	Common	11/05/2026	3000	156682.25

144: Remarks and Signature

Remarks
Date of Notice	11/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert Zerbe.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)